KBio Announces FDA Clearance Of IND For EV68-228-N And First Patient Dosed
28 Jun 2024 //
GLOBENEWSWIRE
KBio Announces Strategic Collaboration with Leaf Expression Systems
28 Sep 2022 //
GLOBENEWSWIRE
28 Jun 2024 //
GLOBENEWSWIRE
28 Sep 2022 //
GLOBENEWSWIRE